These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 26297914)

  • 21. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.
    Litt DJ; Neal SE; Fry NK
    J Clin Microbiol; 2009 Mar; 47(3):680-8. PubMed ID: 19158267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population diversity among Bordetella pertussis isolates, United States, 1935-2009.
    Schmidtke AJ; Boney KO; Martin SW; Skoff TH; Tondella ML; Tatti KM
    Emerg Infect Dis; 2012 Aug; 18(8):1248-55. PubMed ID: 22841154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
    Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA
    Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics of Bordetella pertussis whole-cell and acellular vaccines.
    Möller J; Kraner ME; Burkovski A
    BMC Res Notes; 2019 Jun; 12(1):329. PubMed ID: 31182148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-locus variable-number tandem repeat analysis of Bordetella pertussis isolates circulating in Poland in the period 1959-2013.
    Mosiej E; Krysztopa-Grzybowska K; Polak M; Prygiel M; Lutyńska A
    J Med Microbiol; 2017 Jun; 66(6):753-761. PubMed ID: 28598302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bordetella pertussis from functional genomics to intranasal vaccination.
    Locht C; Antoine R; Raze D; Mielcarek N; Hot D; Lemoine Y; Mascart F
    Int J Med Microbiol; 2004 Apr; 293(7-8):583-8. PubMed ID: 15149035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Variation of Bordetella pertussis in Austria.
    Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U
    PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
    Tsang RS; Sill ML; Martin IE; Jamieson F
    Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pertussis in Argentina and France.
    Caro V; Bouchez V; Guiso N; Gatti B; Agosti MR; Ayala SE
    Vaccine; 2007 May; 25(22):4335-9. PubMed ID: 17229502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.
    Weigand MR; Pawloski LC; Peng Y; Ju H; Burroughs M; Cassiday PK; Davis JK; DuVall M; Johnson T; Juieng P; Knipe K; Loparev VN; Mathis MH; Rowe LA; Sheth M; Williams MM; Tondella ML
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of whooping cough & typing of Bordetella pertussis.
    Hegerle N; Guiso N
    Future Microbiol; 2013 Nov; 8(11):1391-403. PubMed ID: 24199799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insight into evolution of Bordetella pertussis from comparative genomic analysis: evidence of vaccine-driven selection.
    Octavia S; Maharjan RP; Sintchenko V; Stevenson G; Reeves PR; Gilbert GL; Lan R
    Mol Biol Evol; 2011 Jan; 28(1):707-15. PubMed ID: 20833694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surveillance of pertussis: methods and implementation.
    Guiso N; Wirsing von König CH
    Expert Rev Anti Infect Ther; 2016 Jul; 14(7):657-67. PubMed ID: 27224518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
    Gillard J; van Schuppen E; Diavatopoulos DA
    Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acellular pertussis vaccines and pertussis resurgence: revise or replace?
    Ausiello CM; Cassone A
    mBio; 2014 Jun; 5(3):e01339-14. PubMed ID: 24917600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
    Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
    Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.
    Kallonen T; Gröndahl-Yli-Hannuksela K; Elomaa A; Lutyńska A; Fry NK; Mertsola J; He Q
    Infect Genet Evol; 2011 Dec; 11(8):2034-42. PubMed ID: 21964035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bordetella pertussis: why is it still circulating?
    Guiso N
    J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.